Your search returned 74 results.

Results
	61.	Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial. [electronic resource] by Rousseau, Annick Laroche, Marie-Laure Venisse, Nicolas Loichot-Roselmac, Cecile Turcant, Alain Hoizey, Guillaume Compagnon, Patricia Hary, Lionel Debruyne, Danièle Saivin, Sylvie Jacqz-Aigrain, Evelyne Buchler, Mathias Villeneuve, Claire Vergnenègre, Alain Le Meur, Yannick Marquet, Pierre Producer: 20100707 In: Transplantation vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	62.	Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study. [electronic resource] by Borget, Isabelle Pérol, Maurice Pérol, David Lavolé, Armelle Greillier, Laurent Dô, Pascal Westeel, Virginie Crequit, Jacky Léna, Hervé Monnet, Isabelle Le Caer, Hervé Fournel, Pierre Falchero, Lionel Poudenx, Michel Vaylet, Fabien Chabaud, Sylvie Vergnenegre, Alain Zalcman, Gérard Chouaïd, Christos Producer: 20150811 In: BMC cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). [electronic resource] by Chouaid, Christos Dujon, Cecile Do, Pascal Monnet, Isabelle Madroszyk, Anne Le Caer, Herve Auliac, Jean Bernard Berard, Henri Thomas, Pascal Lena, Herve Robinet, Gilles Baize, Nathalie Bizieux-Thaminy, Acya Fraboulet, Gislaine Locher, Chrystele Le Treut, Jacques Hominal, Stephane Vergnenegre, Alain Producer: 20150723 In: Lung cancer (Amsterdam, Netherlands) vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	64.	Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study. [electronic resource] by Bylicki, Olivier Ferlay, Céline Chouaid, Christos Lavolé, Armelle Barlési, Fabrice Dubos, Cathérine Westeel, Virginie Créquit, Jacky Corre, Roman Vergnenègre, Alain Monnet, Isabelle Le Caer, Hervé Fournel, Pierre Vaylet, Fabien Falchero, Lionel Poudenx, Michel Linard, Pauline Pérol, David Zalcman, Gérald Pérol, Maurice Producer: 20140123 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	65.	Real-life experience of ceritinib in crizotinib-pretreated [electronic resource] by Cadranel, Jacques Cortot, Alexis B Lena, Hervé Mennecier, Bertrand Do, Pascal Dansin, Eric Mazieres, Julien Chouaid, Christos Perol, Maurice Barlesi, Fabrice Robinet, Gilles Friard, Sylvie Thiberville, Luc Audigier-Valette, Clarisse Vergnenegre, Alain Westeel, Virginie Slimane, Khemaies Buturuga, Alexandru Moro-Sibilot, Denis Besse, Benjamin Publication details: ERJ open research Jan 2018 In: ERJ open research vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	66.	Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer. [electronic resource] by Molina-Vila, Miguel A Bertran-Alamillo, Jordi Gascó, Amaya Mayo-de-las-Casas, Clara Sánchez-Ronco, María Pujantell-Pastor, Laia Bonanno, Laura Favaretto, Adolfo G Cardona, Andrés F Vergnenègre, Alain Majem, Margarita Massuti, Bartomeu Morán, Teresa Carcereny, Enric Viteri, Santiago Rosell, Rafael Producer: 20150707 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	67.	Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer. [electronic resource] by Pérol, Maurice Chouaid, Christos Pérol, David Barlési, Fabrice Gervais, Radj Westeel, Virginie Crequit, Jacky Léna, Hervé Vergnenègre, Alain Zalcman, Gérard Monnet, Isabelle Le Caer, Hervé Fournel, Pierre Falchero, Lionel Poudenx, Michel Vaylet, Fabien Ségura-Ferlay, Céline Devouassoux-Shisheboran, Mojgan Taron, Miquel Milleron, Bernard Producer: 20121210 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	68.	Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer. [electronic resource] by Karachaliou, Niki Bracht, Jillian Wilhelmina Paulina Fernandez Bruno, Manuel Drozdowskyj, Ana Gimenez Capitan, Ana Moran, Teresa Carcereny, Enric Cobo, Manuel Domine, Manuel Chaib, Imane Ramirez, Jose Luis Camps, Carlos Provencio, Mariano Vergnenegre, Alain Lopez-Vivanco, Guillermo Majem, Margarita Massuti, Bartomeu Rosell, Rafael Producer: 20200408 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	69.	Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. [electronic resource] by Corre, Romain Greillier, Laurent Le Caër, Hervé Audigier-Valette, Clarisse Baize, Nathalie Bérard, Henri Falchero, Lionel Monnet, Isabelle Dansin, Eric Vergnenègre, Alain Marcq, Marie Decroisette, Chantal Auliac, Jean-Bernard Bota, Suzanna Lamy, Régine Massuti, Bartomeu Dujon, Cécile Pérol, Maurice Daurès, Jean-Pierre Descourt, Renaud Léna, Hervé Plassot, Carine Chouaïd, Christos Producer: 20161213 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	70.	Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. [electronic resource] by Hellmann, Matthew D Paz-Ares, Luis Bernabe Caro, Reyes Zurawski, Bogdan Kim, Sang-We Carcereny Costa, Enric Park, Keunchil Alexandru, Aurelia Lupinacci, Lorena de la Mora Jimenez, Emmanuel Sakai, Hiroshi Albert, Istvan Vergnenegre, Alain Peters, Solange Syrigos, Konstantinos Barlesi, Fabrice Reck, Martin Borghaei, Hossein Brahmer, Julie R O'Byrne, Kenneth J Geese, William J Bhagavatheeswaran, Prabhu Rabindran, Sridhar K Kasinathan, Ravi S Nathan, Faith E Ramalingam, Suresh S Producer: 20191127 In: The New England journal of medicine vol. 381 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	71.	Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial. [electronic resource] by Karachaliou, Niki Mayo-de las Casas, Clara Queralt, Cristina de Aguirre, Itziar Melloni, Boris Cardenal, Felipe Garcia-Gomez, Ramon Massuti, Bartomeu Sánchez, José Miguel Porta, Ruth Ponce-Aix, Santiago Moran, Teresa Carcereny, Enric Felip, Enriqueta Bover, Isabel Insa, Amelia Reguart, Noemí Isla, Dolores Vergnenegre, Alain de Marinis, Filippo Gervais, Radj Corre, Romain Paz-Ares, Luis Morales-Espinosa, Daniela Viteri, Santiago Drozdowskyj, Ana Jordana-Ariza, Núria Ramirez-Serrano, Jose Luis Molina-Vila, Miguel Angel Rosell, Rafael Producer: 20160329 In: JAMA oncology vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	72.	BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer. [electronic resource] by Karachaliou, Niki Codony-Servat, Jordi Teixidó, Cristina Pilotto, Sara Drozdowskyj, Ana Codony-Servat, Carles Giménez-Capitán, Ana Molina-Vila, Miguel Angel Bertrán-Alamillo, Jordi Gervais, Radj Massuti, Bartomeu Morán, Teresa Majem, Margarita Felip, Enriqueta Carcereny, Enric García-Campelo, Rosario Viteri, Santiago González-Cao, María Morales-Espinosa, Daniela Verlicchi, Alberto Crisetti, Elisabetta Chaib, Imane Santarpia, Mariacarmela Luis Ramírez, José Bosch-Barrera, Joaquim Felipe Cardona, Andrés de Marinis, Filippo López-Vivanco, Guillermo Miguel Sánchez, José Vergnenegre, Alain Sánchez Hernández, José Javier Sperduti, Isabella Bria, Emilio Rosell, Rafael Producer: 20161010 In: Scientific reports vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	73.	Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. [electronic resource] by Chaib, Imane Karachaliou, Niki Pilotto, Sara Codony Servat, Jordi Cai, Xueting Li, Xuefei Drozdowskyj, Ana Servat, Carles Codony Yang, Jie Hu, Chunping Cardona, Andres Felipe Vivanco, Guillermo Lopez Vergnenegre, Alain Sanchez, Jose Miguel Provencio, Mariano de Marinis, Filipo Passaro, Antonio Carcereny, Enric Reguart, Noemi Campelo, Charo Garcia Teixido, Christina Sperduti, Isabella Rodriguez, Sonia Lazzari, Chiara Verlicchi, Alberto de Aguirre, Itziar Queralt, Cristina Wei, Jia Estrada, Roger Puig de la Bellacasa, Raimon Ramirez, Jose Luis Jacobson, Kirstine Ditzel, Henrik J Santarpia, Mariacarmela Viteri, Santiago Molina, Migual Angel Zhou, Caicun Cao, Peng Ma, Patrick C Bivona, Trever G Rosell, Rafael Producer: 20170602 In: Journal of the National Cancer Institute vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	74.	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. [electronic resource] by Rosell, Rafael Carcereny, Enric Gervais, Radj Vergnenegre, Alain Massuti, Bartomeu Felip, Enriqueta Palmero, Ramon Garcia-Gomez, Ramon Pallares, Cinta Sanchez, Jose Miguel Porta, Rut Cobo, Manuel Garrido, Pilar Longo, Flavia Moran, Teresa Insa, Amelia De Marinis, Filippo Corre, Romain Bover, Isabel Illiano, Alfonso Dansin, Eric de Castro, Javier Milella, Michele Reguart, Noemi Altavilla, Giuseppe Jimenez, Ulpiano Provencio, Mariano Moreno, Miguel Angel Terrasa, Josefa Muñoz-Langa, Jose Valdivia, Javier Isla, Dolores Domine, Manuel Molinier, Olivier Mazieres, Julien Baize, Nathalie Garcia-Campelo, Rosario Robinet, Gilles Rodriguez-Abreu, Delvys Lopez-Vivanco, Guillermo Gebbia, Vittorio Ferrera-Delgado, Lioba Bombaron, Pierre Bernabe, Reyes Bearz, Alessandra Artal, Angel Cortesi, Enrico Rolfo, Christian Sanchez-Ronco, Maria Drozdowskyj, Ana Queralt, Cristina de Aguirre, Itziar Ramirez, Jose Luis Sanchez, Jose Javier Molina, Miguel Angel Taron, Miquel Paz-Ares, Luis Producer: 20120423 In: The Lancet. Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)